XOMA Royalty (XOMA) EPS (Basic) (2011 - 2026)

XOMA Royalty (XOMA) reported EPS (Basic) of $0.38 for Q1 2026, up 89.82% on a YoY basis from $0.2 in Q1 2025, and down 50.36% sequentially from $0.76 in Q4 2025.

XOMA Royalty (XOMA) EPS (Basic) (2011 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of EPS (Basic) data on file, last reported at $0.38 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 89.82% year-over-year to $0.38; the trailing twelve-month figure through Mar 2026 stood at $0.21 (up 104.87% YoY), and the FY2025 full-year result was $2.62, up 323.33% from the prior year.
  • EPS (Basic) declined to $0.38 in Q1 2026, from $0.76 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.76 in Q4 2025 to a low of -$1516.4 in Q2 2023.
  • A 5-year average of -$282.59 and a median of -$1.38 in 2022 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) sank 517226.62% in 2023 and surged 192.59% in 2025, its largest moves.
  • Tracing XOMA's EPS (Basic) over 5 years: stood at -$0.55 in 2022, then plunged by 444.43% to -$2.99 in 2023, then jumped by 72.65% to -$0.82 in 2024, then surged by 192.59% to $0.76 in 2025, then plunged by 50.36% to $0.38 in 2026.
  • Business Quant data shows XOMA's EPS (Basic) at $0.38 in Q1 2026, $0.76 in Q4 2025, and -$0.93 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 XOMA Royalty 478.42 Mn 412.34 Mn - 0.38

Historic Data

Download Data
DateValue
Mar 31, 2026 0.38
Dec 31, 2025 0.76
Jun 30, 2025 -0.93
Mar 31, 2025 0.20
Dec 31, 2024 -0.82
Sep 30, 2024 -1.47
Jun 30, 2024 -2.32
Mar 31, 2024 -931.26
Dec 31, 2023 -2.99
Sep 30, 2023 -1,097.01
Jun 30, 2023 -1,516.40
Mar 31, 2023 -965.71
Dec 31, 2022 -0.55
Sep 30, 2022 -1.28
Jun 30, 2022 -1.82
Mar 31, 2022 -0.19
Dec 31, 2021 2.64
Sep 30, 2021 -0.39
Jun 30, 2021 -0.20
Mar 31, 2021 -0.66